REVENUE (Tables)

6 Months Ended

Jun. 30, 2024

Revenue from Contract with Customer [Abstract]

Schedule of revenue by segment by geographic area

Revenue by segment and geography based on shipped to locations for the three and six months ended June 30, 2024 and 2023 were as follows:

	For the Three Months Ended June 30, 2024
Segment	Europe		Domestic		Latin America		Asia		Total
Aptar Pharma	$	207,493	$	138,734	$	13,301	$	55,005	$	414,533
Aptar Beauty	190,740		66,618		42,207		21,922		321,487
Aptar Closures	51,894		84,468		22,283		15,398		174,043
Total	$	450,127	$	289,820	$	77,791	$	92,325	$	910,063

	For the Three Months Ended June 30, 2023
Segment	Europe		Domestic		Latin America		Asia		Total
Aptar Pharma	$	208,062	$	113,613	$	15,669	$	53,356	$	390,700
Aptar Beauty	211,774		56,940		39,501		21,372		329,587
Aptar Closures	58,810		81,400		20,879		14,530		175,619
Total	$	478,646	$	251,953	$	76,049	$	89,258	$	895,906

	For the Six Months Ended June 30, 2024
Segment	Europe		Domestic		Latin America		Asia		Total
Aptar Pharma	$	419,668	$	264,544	$	25,923	$	111,691	$	821,826
Aptar Beauty	396,930		129,895		80,394		41,588		648,807
Aptar Closures	107,921		173,284		43,556		30,117		354,878
Total	$	924,519	$	567,723	$	149,873	$	183,396	$	1,825,511

	For the Six Months Ended June 30, 2023
Segment	Europe		Domestic		Latin America		Asia		Total
Aptar Pharma	$	400,182	$	228,925	$	23,866	$	93,773	$	746,746
Aptar Beauty	421,126		115,928		76,066		42,856		655,976
Aptar Closures	116,137		166,168		41,245		29,701		353,251
Total	$	937,445	$	511,021	$	141,177	$	166,330	$	1,755,973

Schedule of opening and closing balances of contract assets and contract liabilities

The opening and closing balances of our contract asset and contract liabilities were as follows:

	Balance as of December 31, 2023		Balance as of June 30, 2024		Increase/ (Decrease)
Contract asset (current)	$	18,033	$	13,783	$	(4,250)
Contract liability (current)	60,507		64,435		3,928
Contract liability (long-term)	37,756		42,102		4,346